why choose us

First received: March 04, 2026

Clinical Trial: Personalized Pharmaconutrition Therapy for Myosteatosis, Sarcopenia, and Prognosis in Gastric Cancer Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Myosteatosis

Study Type: INTERVENTIONAL


Official Title: The Effect of Personalised Pharmaconutrition Therapy on Myosteatosis, Sarcopenia and Prognosis in Patients With Gastric Cancer

Brief Summary: This randomized controlled trial aims to evaluate the effect of personalized pharmaconutrition therapy on myosteatosis, sarcopenia, and disease prognosis in patients undergoing surgery due to gastric cancer.Myosteatosis refers to the accumulation of fat within skeletal muscle and is an important indicator of muscle quality and may be associated with postoperative recovery and disease outcomes.A total of 40 patients will be included in the study (20 controls, 20 intervention).In addition to standard nutritional…

Read more